Wiggin and Dana LLP represented Exela Technologies, Inc. on the matter while Goodwin Procter advised UBERDOC. Exela Technologies, Inc. (NASDAQ: XELA), a global business process automation (BPA) leader, announced a...
Exela Technologies, Inc.’s Investment in UBERDOC, Inc.
Gensyn Limited’s $6.5 Million Series Seed Funding Round
Goodwin advised Gensyn Limited on the deal. Gensyn Limited announced its $6.5 million Series Seed funding round. The round was led by Eden Block Fund I LP. Gensyn,...
Zoomo’s Series B Funding Round
Goodwin advised WIND Ventures on the deal. WIND Ventures announced its participation in Zoomo’s latest financing. Zoomo announced a $20 million addition to its Series B funding...
Moderna’s Partnership with Australian Government
Johnson Winter & Slattery worked with Moderna’s US lawyers, Goodwin Procter LLP on the matter. Moderna, a pioneer in mRNA vaccines, signed a 10-year strategic deal with...
Omnipresent’s $120 Million Series B Funding Round
Goodwin advised Omnipresent on the deal. Omnipresent announced its $120m (£90.7m) Series B funding round. The round was led by Kinnevik and Tencent, with participation from Uncorrelated...
LifeMine Therapeutics’ $175 Million Series C Financing
Goodwin advised LifeMine Therapeutics on the deal. LifeMine Therapeutics announced its completion of a $175 million Series C financing. LifeMine Therapeutics is reinventing drug discovery by mining...
Lucca’s €65 Million Financing
Goodwin advised Lucca on the deal. Orrick advised One Peak Partners. Lucca announced its €65 million financing from the London-based investor One Peak. The capital comes from...
Interflora’s Sale of Renaud Distribution
IN BRIEF: Goodwin Procter, advised on the matter. Goodwin Procter advised Interflora with a team including Maxence Bloch (Picture – Corporate M&A). Read the full article...
Acolad’s Acquisition of Ubiqus Group
Goodwin and PwC Société d’Avocats advised EMZ Partners and the founders of Ubiqus Labs on the deal. EMZ Partners and the founders of Ubiqus Labs announced the...
The Routing Company’s $15 Million Series A Financing
Goodwin Procter advised The Routing Company on the deal. The Routing Company announced its $15 million Series A financing led by Galvanize Climate Solutions. The Routing Company...
Sanofi’s Exclusive Collaboration with Seagen
Arnold & Porter advised Sanofi on the deal while Goodwin Procter represented Seagen. Sanofi announced its exclusive collaboration with Nasdaq-listed biotech Seagen Inc. to design, develop and...
Triumvira Immunologics’ $100 Million Series A Financing Round
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...